According to Medpace's latest financial reports the company's current revenue (TTM) is $1.88 B. In 2022 the company made a revenue of $1.45 B an increase over the years 2021 revenue that were of $1.14 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $1.88 B | 29.17% |
2022 | $1.45 B | 27.8% |
2021 | $1.14 B | 23.38% |
2020 | $0.92 B | 7.54% |
2019 | $0.86 B | 22.19% |
2018 | $0.70 B | 61.55% |
2017 | $0.43 B | 3.46% |
2016 | $0.42 B | 17.41% |
2015 | $0.35 B |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | N/A | N/A | ๐บ๐ธ USA |